Akinwande, Olaguoke <br/><br/>
Is radioembolization ((90)Y) better than doxorubicin drug eluting beads (DEBDOX) for hepatocellular carcinoma with portal vein thrombosis? A retrospective analysis.  [electronic resource] 

 -  Surgical oncology  Sep 2015 
 - 270-5 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1879-3320 
<br/><br/><label>Standard No.: </label>10.1016/j.suronc.2015.06.008  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antibiotics, Antineoplastic--therapeutic use<br/>Carcinoma, Hepatocellular--drug therapy<br/>Doxorubicin--therapeutic use<br/>Embolization, Therapeutic<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Liver Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Neoplasm Staging<br/>Portal Vein--pathology<br/>Prognosis<br/>Prospective Studies<br/>Retrospective Studies<br/>Survival Rate<br/>Venous Thrombosis--drug therapy<br/>Yttrium Radioisotopes